Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Metabolic Pharmaceuticals terminated development for obesity in February 2007
Medically reviewed by Valeria Marulanda, FNP-BC (Perfect B, Doral, FL)
This product is intended for laboratory research use only (in vitro)
Cox, Daniel Eichner Published: Drug Testing and Analysis, Volume 7, Issue 1, January 2015, pages 3138 DOI: 10.1002/dta.1715 URL: AOD9604 was incubated in human serum and rat plasma at room temperature to study in vitro metabolic degradation
Metformin (for diabetes), proton pump inhibitors (such as omeprazole or esomeprazole), and H2 blockers (such as famotidine) can all reduce B12 absorption over time
US$ 23.83
US$ 23.43
US$ 29.70
US$ 23.90
US$ 23.95
US$ 27.88
US$ 28.63
US$ 24.29
US$ 24.53
